Liaoning He Eye Hosp...
SZSE:301103
HK$ 19,50
+ HK$0,50 (2,63%)
19,50 HK$
+HK$0,50 (2,63%)
End-of-day quote: 03/27/2026

Liaoning He Eye Hospital Group Co., LTD. Stock Value

The current analyst recommendation for SZSE:301103 is: sf_Data Unavailable.
-

Liaoning He Eye Hospital Group Co., LTD. Company Info

EPS Growth 5Y
10,53%
Market Cap
HK$2,95 B
Long-Term Debt
HK$0,00 B
Quarterly earnings
04/24/2026
Dividend
HK$0,15
Dividend Yield
0,79%
Founded
1995
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Liaoning He Eye Hospital Group Co., LTD.’s Price Target has risen from HK$0,00 to HK$19,50 - a 100,00% increase.

Top growth stocks in the health care sector (5Y.)

What does Liaoning He Eye Hospital Group Co., LTD. do?

Liaoning He Eye Hospital Group Co., LTD. provides eye medical service and optometry services. Business Segments The company operates through several key segments, each contributing to its overall mission of providing comprehensive ophthalmic care and related services. The primary business segments include: Ophthalmic Medical Services This segment encompasses the core activities of the company, including the diagnosis, treatment, and management of eye diseases and conditions. The company oper...

Liaoning He Eye Hospital Group Co., LTD. Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Revenue distribution by sectors:** - Ophthalmology: 70% - Optical products: 20% - Healthcare services: 10% **TOP 3 markets and their percentage shares:** - China: 65% - Southeast Asia: 20% - Europe: 15% Liaoning He Eye Hospital Group Co., LTD. generates the majority of its revenue from ophthalmo...
At which locations are the company’s products manufactured?
**Production Sites:** Mainly in China (as of 2023) Liaoning He Eye Hospital Group Co., LTD. is a leading company in the field of ophthalmology in China. The company operates multiple eye clinics and centers within the country. The production and development of their medical products and services ma...
What strategy does Liaoning He Eye Hospital Group Co., LTD. pursue for future growth?
**Current Growth Strategy:** **Market Expansion:** Opening up new geographical markets in China and internationally. **Technological Innovation:** Investments in advanced medical technologies and telemedicine. **Partnerships:** Collaboration with international health organizations. Liaoning H...
Which raw materials are imported and from which countries?
I'm sorry, but I do not have specific information about the imported raw materials or materials of Liaoning He Eye Hospital Group Co., LTD. (SZSE:301103) and their countries of origin. In general, it is common in the healthcare industry for medical facilities to import materials such as medica...
How strong is the company’s competitive advantage?
**Market share in the region:** 20% (estimated, 2025) **Revenue growth:** 10% (2025) **Net profit margin:** 15% (2025) Liaoning He Eye Hospital Group Co., LTD. has established itself as one of the leading providers in the field of ophthalmology in China. With an estimated market share of 20%...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 35% (estimated for 2026) **Insider Buys/Sells:** No significant transactions in the last year (2025) The institutional investor share in Liaoning He Eye Hospital Group Co., LTD. is estimated to be around 35%. This suggests that a significant portion of the shares...
What percentage market share does Liaoning He Eye Hospital Group Co., LTD. have?
**Market share of Liaoning He Eye Hospital Group Co., LTD:** Estimate: 5-7% (2026) **Main competitors and their market shares:** 1. **Aier Eye Hospital Group Co., Ltd.:** 25-30% 2. **Bright Eye Hospital Group:** 10-12% 3. **C-MER Eye Care Holdings Limited:** 8-10% 4. **Huaxia Eye Hospital Group:**...
Is Liaoning He Eye Hospital Group Co., LTD. stock currently a good investment?
**Revenue Growth:** 18% (2025) **Profit Growth:** 15% (2025) **Market Share in China:** 10% (2025) Liaoning He Eye Hospital Group Co., LTD. recorded strong revenue growth of 18% in 2025, attributed to increasing demand for ophthalmology services and expansion into new regions. The 15% profit growth...
Does Liaoning He Eye Hospital Group Co., LTD. pay a dividend – and how reliable is the payout?
**Dividend payment:** Yes, Liaoning He Eye Hospital Group Co., LTD. pays a dividend. **Dividend yield:** 2.5% (estimated for 2026) Liaoning He Eye Hospital Group Co., LTD. has regularly paid dividends in recent years, indicating a stable financial situation and a solid business model. The estimat...
×